Nusano News
Nusano Achieves Key Technology Milestone Enabling Simultaneous Production of Multiple Radioisotopes
Pairing of custom-built klystrons and fast-pulse modulators enable production of up 12 radioisotopes in a single run Power and efficiency of Nusano system to surpass...
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event
Nusano’s Dr. Howard Lewin will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. Eastern.
Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah
Nusano’s breakthrough production facility will open Q1 2025 in West Valley City, Utah.
Nusano to Present at Jefferies Inaugural Radiopharma Innovation Summit
Nusano is a featured panelist and speaker at Jefferies Inaugural Radipharma Innovation Summit in New York City on April 3, 2023
Chris Lowe Named CEO
VALENCIA, Calif. and WEST VALLEY CITY, Utah, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced Chris Lowe as the company’s Chief Executive Officer. As Nusano progresses toward...
Health-Tech Company Nusano To Open an Office in Utah
SALT LAKE CITY – July 8, 2021 – The Utah Governor’s Office of Economic Opportunity is pleased to announce that Nusano, Inc. will open an office in Utah, adding up to 92 new high-paying Utah jobs in the next 15 years. “Nusano will be an awesome addition to...
Nusano Raises $41M in Seed Round
Nusano (previously known as Alpha Source Inc./Alpha Isotopes) filed paperwork with the United States Securities and Exchange Commission on October 24, 2018 detailing a $41 million seed funding round from investors. With its patented technology, Nusano is working...
BLOG Posts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates